| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A New Diagnosis of Familial Chylomicronaemia Syndrome in a 15-Year-Old Male: From Lab to Clinic
|
Elgerray, S.
|
|
|
57 |
S |
p. 7
|
artikel
|
| 2 |
A tale of 2 pregnancies: the biochemical trends, medical management, and outcomes of hypertriglyceridemia in pregnancy secondary to multi-factorial chylomicronaemia syndrome (MCS) and extreme ketogenic/carnivorous diet
|
Cantley, N.W.P.
|
|
|
57 |
S |
p. 6-7
|
artikel
|
| 3 |
Bempedoic acid: real-world efficacy and tolerability in lipid clinics across three UK Centres
|
Jakubowska, A.
|
|
|
57 |
S |
p. 3
|
artikel
|
| 4 |
Clinical Service Quality and Unmet Needs in Homozygous Familial Hypercholesterolaemia Patients: Insights from UK Tertiary Centres
|
Hussein, Heleen A.
|
|
|
57 |
S |
p. 5
|
artikel
|
| 5 |
Efficacy and safety of statins, ezetimibe and statins-ezetimibe therapies for children and adolescents with heterozygous familial hypercholesterolaemia: Systematic review, pairwise and network meta-analyses of randomised controlled trials
|
Llewellyn, A.
|
|
|
57 |
S |
p. 2-3
|
artikel
|
| 6 |
Genetic Landscape of Familial Chylomicronaemia Syndrome (FCS) and Multifactorial Chylomicronaemia Syndrome (MCS) in United Kingdom
|
Bashir, Bilal
|
|
|
57 |
S |
p. 1
|
artikel
|
| 7 |
HEART UK 37th Annual Medical & Scientific conference
|
|
|
|
57 |
S |
p. 1
|
artikel
|
| 8 |
HMGCoAR autoantibodies: hidden in plain sight?
|
Mercer-Smith, G.
|
|
|
57 |
S |
p. 2
|
artikel
|
| 9 |
Hypertriglyceridaemia and Cardiovascular Autonomic Function in Patients Without Diabetes Mellitus
|
Bashir, Bilal
|
|
|
57 |
S |
p. 4
|
artikel
|
| 10 |
Ketogenic Diet – a culinary delight but is there a cautionary tale?
|
Valaiyapathi, R.
|
|
|
57 |
S |
p. 10
|
artikel
|
| 11 |
Ketogenic diet and extreme hypercholesterolaemia: A case of polygenic hypercholesteroalemia
|
Mazaheri, T.
|
|
|
57 |
S |
p. 8-9
|
artikel
|
| 12 |
Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – Analysis of patient-level LDL-C reduction, fat-soluble vitamins, lipoproteins and patient maturation from the APH-19 study
|
Masana, Luis
|
|
|
57 |
S |
p. 4
|
artikel
|
| 13 |
Real-world efficacy and side effect profile of bempedoic acid in a tertiary centre lipid clinic
|
Moghadam, Kian Parsapour
|
|
|
57 |
S |
p. 9
|
artikel
|
| 14 |
Statin Treatment in Type 1 Diabetes is Not Associated with Diabetic Peripheral Neuropathy
|
Pasha, Raabya
|
|
|
57 |
S |
p. 9
|
artikel
|
| 15 |
Target gene selection and design of precise base editing therapies for atherosclerotic cardiovascular disease
|
Fiedorek, F.T.
|
|
|
57 |
S |
p. 8
|
artikel
|
| 16 |
The long-term, real-world effectiveness and safety of lomitapide in homozygous familial hypercholesterolaemia (HoFH): Nine-year data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)
|
Blom, Dirk
|
|
|
57 |
S |
p. 1-2
|
artikel
|
| 17 |
Total Circulating PCSK9 Positively Correlates with Age and Free Circulating PCSK9 Positively Correlated with Body Mass Index in Healthy Volunteers
|
Kamath, Anoushka
|
|
|
57 |
S |
p. 8
|
artikel
|
| 18 |
Update on the United Kingdom Paediatric FH Register: Working towards new evidence on when children with Familial Hypercholesterolaemia should start lipid lowering therapies
|
Tata, L.J.
|
|
|
57 |
S |
p. 9-10
|
artikel
|
| 19 |
Using cardiovascular and imaging biomarkers to identify patients with familial hypercholesterolaemia
|
Al Hasani, Wiaam
|
|
|
57 |
S |
p. 6
|
artikel
|
| 20 |
Variants in LPA are associated with mutation-negative Familial Hypercholesterolaemia: whole genome sequencing analysis in the 100,000 Genomes Project
|
Bird, Martin
|
|
|
57 |
S |
p. 2
|
artikel
|
Tijdschrift beschrijving